icon
icon
icon
icon
🏷️$300 Off
🏷️$300 Off

News /

Articles /

Pfizer Stock Drops 4.83% in Four Days Amid Probe, Trading Volume Ranks 39th

Market BriefThursday, Mar 27, 2025 7:42 pm ET
1min read

On March 27, 2025, pfizer (PFE) experienced a decline of 0.79%, marking its fourth consecutive day of losses, with a total decrease of 4.83% over the past four days. The trading volume for the day was 12.67 billion, placing it at the 39th position in the daily stock market rankings.

Pfizer's stock has been under pressure due to reports that U.S. prosecutors are investigating claims that the company intentionally delayed announcing the success of its COVID-19 vaccine for political reasons. This probe, reported by The Wall Street Journal, has raised concerns about the timing of Pfizer's vaccine results and its potential impact on public health decisions.

Despite the investigation, analysts at Citi have maintained a Neutral rating on Pfizer stock with a price target of $27.00. The firm believes that the probe is unlikely to have a significant long-term impact on the company's operations or financial performance. Citi's analyst, Geoff Meacham, noted that Pfizer's strong portfolio of drugs and vaccines, along with its robust pipeline, should continue to drive growth in the coming years.

Pfizer's fourth-quarter earnings report showed a 21.9% year-over-year increase in revenues, totaling $17.76 billion. This exceeded analysts' expectations by 3%, highlighting the company's strong performance in the quarter. However, the stock has declined by 3.8% since the earnings release, reflecting investor concerns about the ongoing probe and the broader challenges facing the pharmaceutical industry.

Looking ahead, Pfizer is well-positioned to benefit from advancements in precision medicine and the increasing adoption of AI in drug development. However, the company also faces headwinds such as regulatory scrutiny, pricing pressures, and patent cliffs for key blockbuster drugs. Despite these challenges, Pfizer's strong portfolio and innovative pipeline should help it navigate the complex operating environment and continue to deliver value to shareholders.

Comments

Add a public comment...
Post
User avatar and name identifying the post author
Elibroftw
03/28
$PFE never seen a stock held back like this one
0
Reply
User avatar and name identifying the post author
Surfin_Birb_09
03/28
$PFE only God can help us now
0
Reply
User avatar and name identifying the post author
Opening_AI
03/28
@Surfin_Birb_09 Holding long on $PFE? Worried about the probe impact?
0
Reply
User avatar and name identifying the post author
Victoria
03/28

It wasn’t until I discovered the transformative potential of Bitcoin trading that my fortunes began to change. Bitcoin, with its unparalleled volatility and profit potential, presented a new avenue for wealth accumulation that I couldn’t ignore. And it was through the expert guidance of Catherine E. Russell, a seasoned trading manager on Facebook, that I finally found the success I had been seeking.
Catherine’s proficiency in navigating the complex world of cryptocurrency trading is truly remarkable. Her strategic insights, impeccable timing, and disciplined approach have enabled me to achieve consistent daily profits and regain confidence in my investment endeavors. Under her guidance, I’ve experienced firsthand the immense opportunities that the crypto market has to offer, and I firmly believe that you could benefit from her expertise as well.

0
Reply
User avatar and name identifying the post author
Bitter_Face8790
03/28
@Victoria Fair enough
0
Reply
User avatar and name identifying the post author
Mr_Biddz
03/28
$PFE threw in a smiley 😂 anything under 25 is crazy
0
Reply
User avatar and name identifying the post author
Frozen_turtle__
03/28
$PFE has dropped so low that I can't sell covered calls at a decent price to make a profit. Hoping it gets back to 30 by mid summer. Need some big news to make that happen
0
Reply
User avatar and name identifying the post author
deevee12
03/27
Pfizer's stock may be under pressure, but like a diamond, it's only getting stronger
0
Reply
User avatar and name identifying the post author
JuniorCharge4571
03/28
@deevee12 What makes you so bullish on PFE?
0
Reply
User avatar and name identifying the post author
nicpro85
03/27
Citi's analyst thinks Pfizer's pipeline is fire, but the market's giving them grief. Interesting times for $PFE.
0
Reply
User avatar and name identifying the post author
Elibroftw
03/28
@nicpro85 What do you think about Pfizer's future?
0
Reply
User avatar and name identifying the post author
Zestyclose_Gap_100
03/27
Pfizer's vaccine results timing feels sketchy, but Citi thinks it's no biggie. Neutral rating holds. What do you think, long-term impact or nah?
0
Reply
User avatar and name identifying the post author
Current_Attention_92
03/27
PFE's got a solid earnings beat, but the probe's got investors spooked. 🤔 Keeping an eye on how this plays out.
0
Reply
User avatar and name identifying the post author
shackofcards
03/27
Pfizer's got a vaccine win but investors spooked by that probe. 🤔 Long-term, I'm holding.
0
Reply
User avatar and name identifying the post author
anonymus431
03/28
@shackofcards How long you planning to hold PFE? Got a target price in mind?
0
Reply
User avatar and name identifying the post author
PancakeBreakfest
03/27
4.83% drop ain't too shabby a sale, IMO. Grabbing a small position, hoping for a bounce back. Anyone else buying the dip?
0
Reply
User avatar and name identifying the post author
Virtual_Information3
03/28
@PancakeBreakfest Bought a small bag too, thinking similar vibes. Holding for the long haul, let's see how it pans out.
0
Reply
User avatar and name identifying the post author
nadescot
03/28
@PancakeBreakfest How long you planning to hold PFE? Got a target in mind or just riding the wave?
0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App